CIRCADIAN FLUCTUATIONS OF TISSUE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGENS IN VASOSPASTIC ANGINA

被引:38
|
作者
SAKATA, K
HOSHINO, T
YOSHIDA, H
ONO, N
OHTANI, S
YOKOYAMA, S
MORI, N
KABURAGI, T
KURATA, C
URANO, T
TAKADA, Y
TAKADA, A
机构
[1] HAMAMATSU UNIV SCH MED, DEPT INTERNAL MED 3, HAMAMATSU, SHIZUOKA 43131, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT PHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
关键词
D O I
10.1016/0002-8703(92)90964-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To elucidate the circadian variation of fibrinolytic components in vasospastic angina, plasma levels of tissue plasminogen activator antigen (t-PA), free plasminogen activator inhibitor antigen (free PAI-1), t-PA/PAI-1 complex, and total PAI-1 were measured in venous plasma samples. Samples were taken every 6 hours (6:00 AM, noon, 6:00 PM, and midnight) for 24 hours in 14 patients with vasospastic angina, in 9 patients with exertional angina, and in 19 normal subjects. Twenty-four-hour Holter monitoring (Holter monitor, Del Mar Avionics, Irvine, Calif.) was also carried out in all subjects. All of the fibrinolytic components showed circadian variation, with a peak level at 6:00 AM in every study group except for the t-PA/PAI-1 complex in the group of patients with exertional angina. The values for all of the fibrinolytic components at each sampling time were higher in patients with coronary artery disease than in normal subjects. In particular, the mean value of free PAI-1 at 6:00 AM in patients with vasospastic angina was significantly higher than that in normal subjects and that in patients with exertional angina. This value of free PAI-1 in patients with vasospastic angina was closely associated with the duration of ischemic attacks. These results suggested that the circadian fluctuation of fibrinolytic components may be an important factor that leads to coronary thrombosis at the time of coronary spasm, especially in the early morning.
引用
收藏
页码:854 / 860
页数:7
相关论文
共 50 条
  • [31] HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 DEFICIENCY
    FAY, WP
    SHAPIRO, AD
    SHIH, JL
    SCHLEEF, RR
    GINSBURG, D
    CIRCULATION, 1992, 86 (04) : S12 - S12
  • [32] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 AFTER EXERCISE - COMPARISON TO VENOUS OCCLUSION AND DDAVP
    VENE, N
    STEGNAR, M
    FIBRINOLYSIS, 1990, 4 : 105 - 107
  • [33] TISSUE PLASMINOGEN-ACTIVATOR AND PLACENTAL PLASMINOGEN-ACTIVATOR INHIBITOR IN HUMAN GINGIVAL FLUID
    KINNBY, B
    LECANDER, I
    MARTINSSON, G
    ASTEDT, B
    FIBRINOLYSIS, 1991, 5 (04) : 239 - 242
  • [34] THE ACUTE EFFECT OF INSULIN ON TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN MAN
    LANDIN, K
    TENGBORN, L
    CHMIELEWSKA, J
    VONSCHENCK, H
    SMITH, U
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (02) : 130 - 133
  • [35] THE PHARMACOKINETICS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN THE RABBIT
    MAYER, EJ
    FUJITA, T
    GARDELL, SJ
    SHEBUSKI, RJ
    REILLY, CF
    BLOOD, 1990, 76 (08) : 1514 - 1520
  • [36] THE SIGNIFICANCE OF FIBRIN BINDING BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 FOR THE MECHANISM OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR MEDIATED FIBRINOLYSIS
    STRINGER, HAR
    PANNEKOEK, H
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1004 - 1004
  • [37] TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH LIVER-CIRRHOSIS
    LASIERRA, J
    AZA, MJ
    VILADES, E
    POBLET, S
    BARRAO, F
    BAYON, E
    GONZALEZ, J
    FIBRINOLYSIS, 1991, 5 (02) : 117 - 120
  • [38] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN RAYNAUD PHENOMENON
    SILVERI, F
    SERRETTI, R
    CORE, P
    BRECCIAROLI, D
    THROMBOSIS RESEARCH, 1993, 70 : S93 - S93
  • [39] AMINO-ACID-RESIDUES THAT AFFECT INTERACTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR WITH PLASMINOGEN-ACTIVATOR INHIBITOR-1
    MADISON, EL
    GOLDSMITH, EJ
    GERARD, RD
    GETHING, MJH
    SAMBROOK, JF
    BASSELDUBY, RS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) : 3530 - 3533
  • [40] AGE-RELATED-CHANGES IN THE BASAL LEVEL OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    STEGNAR, M
    PENTEK, M
    FIBRINOLYSIS, 1992, 6 : 55 - 57